PCVX logo

Vaxcyte (PCVX) Operating expenses

annual operating expenses:

$569.55M+$176.50M(+44.91%)
December 31, 2024

Summary

  • As of today (July 3, 2025), PCVX annual total operating expenses is $569.55 million, with the most recent change of +$176.50 million (+44.91%) on December 31, 2024.
  • During the last 3 years, PCVX annual operating expenses has risen by +$467.46 million (+457.91%).
  • PCVX annual operating expenses is now at all-time high.

Performance

PCVX Operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXincome statement metrics

quarterly operating expenses:

$180.79M+$17.81M(+10.93%)
March 31, 2025

Summary

  • As of today (July 3, 2025), PCVX quarterly total operating expenses is $180.79 million, with the most recent change of +$17.81 million (+10.93%) on March 31, 2025.
  • Over the past year, PCVX quarterly operating expenses has increased by +$66.32 million (+57.94%).
  • PCVX quarterly operating expenses is now at all-time high.

Performance

PCVX quarterly operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXincome statement metrics

Operating expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

PCVX Operating expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+44.9%+57.9%
3 y3 years+457.9%+362.9%
5 y5 years+956.4%+563.0%

PCVX Operating expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+457.9%at high+283.1%
5 y5-yearat high+956.4%at high+845.2%
alltimeall timeat high+1502.9%at high+1395.9%

PCVX Operating expenses History

DateAnnualQuarterly
Mar 2025
-
$180.79M(+10.9%)
Dec 2024
$569.55M(+44.9%)
$162.98M(+16.7%)
Sep 2024
-
$139.63M(-8.5%)
Jun 2024
-
$152.59M(+33.3%)
Mar 2024
-
$114.47M(-9.5%)
Dec 2023
$393.04M(+87.8%)
$126.44M(+13.5%)
Sep 2023
-
$111.39M(+31.5%)
Jun 2023
-
$84.68M(+20.1%)
Mar 2023
-
$70.54M(+9.2%)
Dec 2022
$209.26M(+105.0%)
$64.58M(+10.6%)
Sep 2022
-
$58.42M(+23.8%)
Jun 2022
-
$47.20M(+20.8%)
Mar 2022
-
$39.06M(+35.0%)
DateAnnualQuarterly
Dec 2021
$102.08M(+17.2%)
$28.94M(+8.6%)
Sep 2021
-
$26.65M(+14.1%)
Jun 2021
-
$23.35M(+0.9%)
Mar 2021
-
$23.14M(+21.0%)
Dec 2020
$87.10M(+61.6%)
$19.13M(-6.8%)
Sep 2020
-
$20.52M(+1.6%)
Jun 2020
-
$20.19M(-26.0%)
Mar 2020
-
$27.27M(+74.2%)
Dec 2019
$53.92M(+51.7%)
$15.66M(+29.5%)
Sep 2019
-
$12.09M(-1.2%)
Jun 2019
-
$12.23M(-12.3%)
Mar 2019
-
$13.94M
Dec 2018
$35.53M
-

FAQ

  • What is Vaxcyte annual total operating expenses?
  • What is the all time high annual operating expenses for Vaxcyte?
  • What is Vaxcyte annual operating expenses year-on-year change?
  • What is Vaxcyte quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Vaxcyte?
  • What is Vaxcyte quarterly operating expenses year-on-year change?

What is Vaxcyte annual total operating expenses?

The current annual operating expenses of PCVX is $569.55M

What is the all time high annual operating expenses for Vaxcyte?

Vaxcyte all-time high annual total operating expenses is $569.55M

What is Vaxcyte annual operating expenses year-on-year change?

Over the past year, PCVX annual total operating expenses has changed by +$176.50M (+44.91%)

What is Vaxcyte quarterly total operating expenses?

The current quarterly operating expenses of PCVX is $180.79M

What is the all time high quarterly operating expenses for Vaxcyte?

Vaxcyte all-time high quarterly total operating expenses is $180.79M

What is Vaxcyte quarterly operating expenses year-on-year change?

Over the past year, PCVX quarterly total operating expenses has changed by +$66.32M (+57.94%)
On this page